A commonly expressed protein in skin – periostin – can directly activate itch-associated neurons in the skin. Blocking periostin receptors on these neurons reduced the itch response in a mouse model of atopic dermatitis, or eczema.
There is no data to suggest that continuing allergy and asthma medications will have any effect on increasing your risk of getting the COVID-19 infection, or if you get the infection, lead to a worse outcome.
As the global pandemic continues and its impact increasingly disrupts daily life in the U.S., a new ongoing survey launched this week reveals specific concerns about the novel coronavirus among people living with chronic illnesses, who feel these conditions make them more susceptible to the virus (73%) and are beginning to turn to each other (58%) and their doctors (36%) for more information.
COVID-19 is causing confusion and anxiety for many, including those with asthma. The American College of Allergy, Asthma and Immunology advises staying on your asthma medications to keep asthma under control.